Advisory Services Network’s Aimmune Therapeutics AIMT Stock Holding History

Advisory Services Network’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-164	Closed	-$6K	–	3938
2020 Q3	$6K	Sell	164 -10,936	-99%	-$233K	﹤0.01%	2737
2020 Q2	$185K	Buy	11,100 +6,600	+147%	+$112K	0.01%	951
2020 Q1	$65K	Buy	+4,500	New	+$115K	﹤0.01%	1262

Advisory Services Network's AIMT Position: Q4 2020 in Review

Advisory Services Network sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 164 shares — an estimated $6K sold.

Advisory Services Network first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $185K in Q2 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Advisory Services Network reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Advisory Services Network sold 164 Aimmune Therapeutics shares in Q4 2020, an estimated $6K.
Advisory Services Network first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
Advisory Services Network's Aimmune Therapeutics position peaked at $185K in Q2 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.